Literature DB >> 22476059

A new antihypertensive drug ameliorate insulin resistance.

Yan-xia Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22476059      PMCID： PMC4003370          DOI： 10.1038/aps.2012.31

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  15 in total

Review 1.  Cardiovascular ATP-sensitive K+ channel as a new molecular target for development of antihypertensive drugs.

Authors:  H Wang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1998-09

2.  Chemerin/ChemR23 signaling axis is involved in the endothelial protection by K(ATP) channel opener iptakalim.

Authors:  Rui-jun Zhao; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

3.  Iptakalim: a new or just another KCO?

Authors:  Alexandre D T Costa
Journal:  Cardiovasc Res       Date:  2009-06-10       Impact factor: 10.787

4.  Glucose metabolism in patients with essential hypertension.

Authors:  Juan García-Puig; Luis M Ruilope; Manuel Luque; Jaime Fernández; Rafael Ortega; Rafael Dal-Ré
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

Review 5.  Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.

Authors:  ZhiYuan Pan; JingHui Huang; WenYu Cui; ChaoLiang Long; YanFang Zhang; Hai Wang
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

Review 6.  Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Authors:  Jeong-a Kim; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Circulation       Date:  2006-04-18       Impact factor: 29.690

Review 7.  Insulin resistance and hypertension.

Authors:  James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05       Impact factor: 4.733

Review 8.  Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.

Authors:  Michelle A Vincent; Monica Montagnani; Michael J Quon
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

9.  Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.

Authors:  Ozgur Bahadir; Mehmet Uzunlulu; Aytekin Oguz; Muzeyyen A Bahadir
Journal:  Hypertens Res       Date:  2007-01       Impact factor: 3.872

10.  Iptakalim: A novel multi-utility potassium channel opener.

Authors:  Pranav Sikka; Seema Kapoor; V K Bindra; Manish Saini; K K Saxena
Journal:  J Pharmacol Pharmacother       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.